1 |
Mukhopadhyay N, Shukla A, Makhal PN, Kaki VR. Natural product-driven dual COX-LOX inhibitors: Overview of recent studies on the development of novel anti-inflammatory agents. Heliyon 2023. [DOI: 10.1016/j.heliyon.2023.e14569] [Reference Citation Analysis]
|
2 |
Mahnashi MH, Alam W, Huneif MA, Abdulwahab A, Alzahrani MJ, Alshaibari KS, Rashid U, Sadiq A, Jan MS. Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches. Molecules 2023;28. [PMID: 36838577 DOI: 10.3390/molecules28041589] [Reference Citation Analysis]
|
3 |
Alshehri OM, Alshamrani S, Mahnashi MH, Alshahrani MM, Khan JA, Shah M, Alshehri MA, Zafar R, Zahoor M, Jan MS, Hassan SSU, Sadiq A, Khan B. Phytochemical Analysis, Total Phenolic, Flavonoid Contents, and Anticancer Evaluations of Solvent Extracts and Saponins of H. digitata. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/9051678] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
4 |
Alqahtani YS, Jan MS, Mahnashi MH, Alyami BA, Alqarni AO, Rashid U, Mahmood F, Tariq M, Sadiq A, Perrone MG. Anti-Inflammatory Potentials of β-Ketoester Derivatives of N-Ary Succinimides: In Vitro, In Vivo, and Molecular Docking Studies. Journal of Chemistry 2022;2022:1-11. [DOI: 10.1155/2022/8040322] [Reference Citation Analysis]
|